# Intensity Therapeutics, Inc.: Form 8-K, filed Jul 5, 2023

- Company: [Intensity Therapeutics, Inc.](/companies/ints.md) (CIK 1567264)
- Form: 8-K
- Filed: 2023-07-05
- Accepted by EDGAR: Jul 5, 2023, 16:47 ET
- Period: 2023-06-29
- Accession: 0001213900-23-054818
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1567264/000121390023054818/ea181296-8k_intensity.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1567264/000121390023054818/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1567264/000121390023054818/ea181296-8k_intensity.htm

Filed Jul 5, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-054818. Last ingested by Listed: Nov 5, 2026, 12:12 ET. No prices; not investment advice.